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INTRODUCTION 
In a number of animals, there appear to be various 
sites of low resistance to transplants (15,16,24,32). The 
skin from all appearances, is the antithesis to this. that 
is to say, in the majority of cases, the fate of tissue 
transplanted to the skin is ultimate rejection. As atated 
by F. Wise in 1936 (41): 
"As to the skin as a whole, I cannot forebear 
to quote from two of our contemporaries, ' ••• 
Medicine will learn to regard the skin as a 
highly differential parenchymatous organ of 
special significance in immunologic as well 
as in physical and chemical protection." 
Transplantations to skin and of skin have been 
for centuries and the work amassed in these endeavors is 
quite formidable. A relatively few have experimented with a 
single stratum of the skin, the majority electing to con-
sider the skin as a single unit. In this study, I have 
attempted to furthef clarify the role played by a single 
lay~:r of the skin, the tela subcutanea or '!subcutaneous 
t.issuen (25) in th'e active rejection of homotransplants. 
REVIEW OF THE LITERATURE 
1. Early History 
The first attempts of man to transplant to the 
skin date far back into the 7th or 8th century B.C. Hindu 
surgeons at that time were known to use transplantation as 
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a means of repairing amputated noses. This procedure as 
described by the Hindu surgeon, Sushruta, (1,7) would be 
classified today as a form of flap transplantation. Sir 
Harold Gillies (13) asserts that the earliest endeavor at 
homografting to the skin of a human being was recorded in 
1503 A.D. At this time, a poet named Calenzio had written 
the praises of a skilled surgeon called Branca who performed 
homotransplants to the nose. Legend records that at least 
one of his transplants failed, but undoubtedly, as our 
present experience shows, they all must have failed. The 
aforementioned Branca, the elder, and his son, Antonio, 
left no documents on their surgical methods; however, by 
word of mouth and by references as to their ~ork by Calenzio 
and other writers of the day, a surgeon named Tagliacozzi 
was able to piece the procedure together. This selfsame 
Tagliacozzi is generally considered the father of plastic 
surgery as it is known today (14). 
2. Problems in Homotransplantation 
The field of transplantation in general is fraught 
with problems of tissue rejection. At this time, I should 
like to discuss such difficulties as are indigenous to the 
area of skin homografting. Billingham's work in this area 
(2) has shown that the skin shares some antigens with every 
other tissue of the body with the possible exception of 
erythrocytes. These antigens appear to be directly respon-
sible for the rejection of skin homografts by most higher 
animals. The source of this antigenic material is not yet 
known. 
Gaines (12) has clearly outlined the inter-
relationships of skin disorders and the malfunctioning of 
other body systems based upon their mutual phylogenetic 
and histogenetic derivation from embryonic ectoderm. This, 
in part, explains the mechanisms involved which lead to 
the communal sharing of antigens by these systems. Also, 
Kahn (20) has shown by his work that different body tissues 
in the same individual have wide variations in their defens-
ive responses to given amounts of foreign antigenic material. 
The defensive response is described as a "localizing" 
capacity. For example, the "localizing" capacity of skeletal 
muscle was found to be one-tenth that of skin. Thus it 
follows that homograft rejection in skeletal muscle is less 
than that of skin. 
In contradiction to Kahn's work, the results 
obtained by Teir (36,37,38) seem to show that the skin has a 
growth stimulating, rather than inhibiting factor. 
According to Longmire, (23) homotransplants are 
only satisfactory when relatively acellular,inert tissues 
such as bone and cartilage are used. He reasons that this 
is due to the inert tissue acting only as a supporting 
structure for the host's own invading tissue. 
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Southam showed that live cells of either a normal 
or a cancerous nature, when implanted under the skin of 
normal humans, resulted in the eventual rejection of the 
implant. Conversely, humans having a neoplasm at the time 
of ~mplantation, do not reject the implant but rather, the 
latter results in viable tumors (35). Koelsche (21) has 
tried to explain this phenomenon by asserting that cancer 
cells will only grow in transplants from one animal to 
another if the recipient can recognize "self-identity 
markers" in the transplanted tissue (!.e. The transplant 
must have properties similar to that of the recepient's 
normal tissue.) 
One of the few cases of a skin homograft success 
between two normal humans was described by Foster and 
Hanrahan in 1948 (11). An antihistaminic drug was given to 
the recipient and a split-thickness graft from a white male 
was transplanted to a full-thickness defect in a negro 
female. The case was followed for 60 days post operatively 
with the graft functioning normally during this time. 
Unfortunately, this was the only case of this type which the 
authors had experience with and they drew no conclusions 
from it. 
There are a number of works which deal with the 
skin and local immune reactions produced by foreign antigens. 
Cannon observed that a local subcutaneous injection into 
previously mobili~ed histiocytic tissue led to the local 
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formation and retention of immune bodies relatively high in 
concentration (4). The immune bo~ies then diffused out and 
were recovered in lower concentrations in organs elsewhere. 
This, Cannon claimed, seemed to indicate that local 
immunization takes place wherever possible. ¢rskov (31) 
determined that the rapid decrease in the amount of virus 
recovered from the skin of rabbits infected with vaccinia 
was due to local antibody production. He also showed that a 
form of virus neutralizing antibody could be recovered from 
the skin four days after infection. Research by Haxthausen 
(19) showed that an intracutaneous injection of foreign 
antigen evoked a stronger hypersensitivity of the cutaneous 
regions than did a similar injection delivered intravenously. 
He went on to theorize that substances which are not antigens 
from a humoral point of view may nonetheless give rise to the 
formation of antibodies in the skin. Rabinovici (33) X-rayed 
a series of rats and produced a marked and demonstrable 
reduction in the circulating lymphocytes of the body. Skin 
was then homografted to these rats, but the grafts were 
destroyed in the same manner and rate as in nonirradiated 
rats. This appears to support the argument that the 
circulating lymphocytes in the body do not play a part in 
skin transplant rejection. The experiments by Oakley showed 
for the first time that there is antibody production in the 
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fat and voluntary muscle of an animal (30). He also found 
that there was no consistent evidence fer such production 
in the liver, spleen, kidney, or bone marrow. Williams, 
using neoplastic grafts in vivo, arrived at the conclusion 
that subcutaneous tumor transplants are ultimately rejected. 
Such destruction, he reasoned, is a function of the degree 
of vascularization of the transplant (40). Lastly, the in vivo 
work of Thorbecke (39) show that an immunizing injection 
given subcutaneously produced 22.4% more antibodies than did 
an injection of identical concentration given intravenously. 
3. Theories of Skin Homotransplant Failure 
Medawar (29) has limited his speculation on 
transplant failure to the following three hypotheses: blood 
incompatability, genetico-cellular differences, and acquired 
active immunity. He also expressed the opinion that antibodies 
which are generated by the introduction of a homograft 
prevent the completion of cellular mitosis (27). It is for 
this reason that foreign antigenic material, when trans-
planted, will not grow successfully. Additional evidence 
from McMaster (26) and Danforth (5) has suggested that homo-
graft rejection is the result of acquired immunity. This 
conclusion is based upon both researchers', independent 
of each other, having found lymphoid cells surrounding the 
transplant and large numbers of lymphoid cells in the 
peripheral blood. A theory of tissue incompatability due to 
organismal differentials has been advanced by Loeb (22). 
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Meanwhile, Ehrich et al. have shown that lymphoid cells may 
be a precursor for or the carrier of immune bodies (9). 
Harris (18) has proposed that transplant rejection 
takes place in the following manner: the antigens are broken 
down physiologically into smaller soluble particles which 
retain their individual groupings characteristic of the 
original antigenic material. These soluble particles are 
carried to the regional lymph nodes and lymphatic tissue. 
In this way, the antigenic particles can stimulate the anti-
body synthesizing mechanism of the lymphatic tissue. To 
further complicate matters, the work by Ehrich (9) and 
Darey (6) has implicated an additional cell entering into 
the transplant destruction mechanism with the lymphocyte. 
This additional cell is very similar to a plasma cell. 
Rostenberg's theory of transplant rejection is based upon 
the primitive reticulum cell (34). When this cell comes into 
contact with an antigen, an enzymatic adaptation takes place. 
Since this alteration takes place in a primitive reticulum 
cell, the change can be passed on to descendants of this 
cell (~lymphocytes and/or plasma cells). These cells, 
assuming that they are capable of synthesizing globulin, 
would now synthesize an altered globulin (antibody) because 
of the inherited enzymatic modifications. Thus, the anti-
body would have a specificity against the antigen which 
initially caused the adaptation in the enzyme system of the 
reticulum cell. The latest work by Medawar, in 1961, has 
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brought about the "stem cell theory" (29). The theory states 
~hat sensitization occurs in mature cells, while there is an 
induction of tolerance in the immature or primitive cells. 
This is in complete opposition to Rostenberg's theory. 
Brent's more :recent work has given support to the "stem 
cell theory" (3). 
The work done by ~rskov (31), Haxthausen (19), 
and Rabinovici (33) has shown that the lymphocytes which 
circulate in the body do not play an active role in trans-
plant rejection by the skin as formerly thought. These 
works concur with the hypothesis of Cannon (4). It is the 
purpose of this study to attempt to demonstrate that trans-
plant rejection by the skin is gre~ly influenced by the 
subcutaneous tissue. That is to say, the latter tissue is an 
independant producer of a factor or group of factors which 
render transplant immunity. 
METHODS 
A rat neoplasm, the Walker 256 carcinoma (8), wss 
chosen as my material for implantation. Malignant tissue was 
chosen because such tissue normally has a tendency to 
increase in size. It was determined to use this latter 
property as the governing criterion for a successful trans-
plant. In this way, the confusion inherent in determing 
the success or failure of a transplant (17) was avoided. 
The material for each test group and its controls is provided 
by a single tumor. This eliminates problems arising from 
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variation in tumor viability. 
The donor and recipient animals of the Walker 
carcinoma were Sprague-Dawley male rats weighing approximate-
ly 150 grams each. Males were chosen over females due to 
the former group's having an increased susceptibility to 
neoplasmic growth. The site of implantation for the test 
animals was the subcutaneous tissue on the left side of the 
back, and that for the control animals was the retro-
peritoneal area behind the left kidney. The retroperitoneal 
area was chosen for the control series because it had 
similar embryonic origin and vascularity. 
The details of the procedure are as follows: A 
portion of the growing neoplasm (7-8 days after trans-
plantation) is surgically removed from the donor rat and 
placed in a tissue press. The material is passed through 
the press five times and then transferred to a tissue 
grinder (Fisher, pyrex glass, 16mm. x 150 mm.) in order to 
obtain as much homogenization as possible. To the mince is 
added .4 gms. of penicillin-streptolysin and the volume 
adjusted with 85% saline to produce the desired concen-
tration of tumor cells in a volume of .1 ml. A portion of 
skin on the back of the test rats is dissected on three 
sides and the resultant flap turned back so as to expose 
the subcutaneous tissue directly. The tumor homograft 
having been introduced by means of a #18 hypodermic needle, 
the flap is sutured back in place. A midline incision is 
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made on the control rats and the viscera moved aside so as 
to allow the hypodermic needle to insert the transplant 
into the retroperitoneal area. The incision is closed and 
sutured in the standard surgical manner. Sterile technique 
is maintained throughout the procedure. Each rat is then 
placed in an individual cage. This latter precaution is 
taken so as to insure that rats weakened by the carcinoma 
will not be molested by others in the same cage. 
I. Test vs Control 
The first series of experiments was performed in 
order to establish the relationship of the test injection 
site to the control injection site. Each group,containing 
18 rats, received .1 ml. of a 10~ Walker carcinoma mince. 
The rats were checked daily and the day of death recorded. 
2. Position Effect 
An experiment was run in order to determine 
whether the longer surviTal rate of the subcutaneously 
implanted series was due to some factor inherent in the 
tissue itself, or merely a position effect. The implanta-
tion site for this experiment was the rat testis and the 
control site was the retroperitoneal area. The testis was 
chosen not only because it posessed physical properties 
found in subcutaneous tissue, but also because the vascularity 
and embryonic origin of the testis was homologous to both 
the retroperitoneal and subcutaneous tissues. Each of the 
12 test and 18 control animals received a .1 ml. of a 10~ 
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carcinoma mince. The rats were checked daily and the day of 
death recorded. 
3. Dosage Effect 
To ascertain the effect of dosage upon the results 
obtained from the test and control sites, several series of 
experiments were run varying the Walker carcinoma mince 
concentration from 5% to .1% per .1 ml. of implant. The 
number of rats used for each series of experiments varied. 
The rats were checked daily and the day of death recorded. 
4. Transferral of Resistance 
In order to determine the transferability of the 
"re·sista.nce to implantation fac-tor (RIP)" encountered in 
the subcutaneous tissue in the previous experiments, three 
groups of rats, with 36 rats in each group, were handled in 
the following manner: All groups were implanted retro-
peritoneally with a. 1% mince of Walker 256 carcinoma. The 
cellular concentration of the implant was 1%/.lml. The 
implant of the control group was adjusted to the proper con-
centration with 85% saline; the second group had its implan-t 
concentration adjusted with a 1% subcutaneous tissue extract. 
The extract is made be obtaining a mince of the subcutaneous 
tissue and then extracting cells cells and fluid with 85% 
saline. Lastly, the third group received implants adjusted 
to the proper concentration with the resultant supernatant 
obtained by centrifuging the extract of the subcutaneous 
tissue at 3000 r.p.m. for 15 minutes. All the rats were 
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checked daily and the day of death recorded. 
RESULTS 
1. Test TS Control 
The differential response to identical homograft 
implants by the test and control sites is clearly evident 
in Fig. 1. No overlap of the mean day of survival for each 
group is observed, and the results obtained fall well within 
the range of normal distribution. 
2. Position Effect 
The curve obtained from the testis injected rats 
closely approximates that of the control (Fig. 2), with the 
mean days of survival overlapping one another. This is the 
type of result that one would obtain when the location of 
the homograft implant is not a determing factor. 
3. Dosage Effect 
The various dosages of the Walker carcinoma mince 
are observed to alter the response of the subcutaneous 
tissue to the homograft implant (Figs. 1,3,4,5,6,7). A given 
concentration in the subcutaneously implanted groups brought 
about a shorter survival rate as the dosage was increased 
(Fig. 8). The group which was subcutaneously implanted with 
a concentration of .1% had 100% non-takes (Fig. 3). 
4. Transferral of Resistance 
In Fig. 9, it is shown that .a saline extract of 
subcutaneous tissue is capable of imparting homograft 
resistance to a given area. The graph also shows that when 
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compared with Group I (control group), Group II had a mean 
survival differential of 2.3 days, and Group III had a mean 
survival differential of 12.2 days 
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The figure in parenthesis indicates the number of animals in that group. 
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The figure in parenthesis indicates the number of animals in that group. 
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The figure in parenthesis indicates the number of animals in that group. 
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DISCUSSION 
The determination of a differential response to a 
homograft implant by two homologous tissues has been presented. 
The results obtained seem to show that subcutaneous tissue 
is an independant producer of transplant resistance. This 
is consistent with the theory of local immunization as 
proposed by Cannon (4) and others. The position occupied 
by the implant has been shown to exert no influence upon the 
results obtained. That is to say, a tissue which is similar 
to the subcutaneous tissue and homologous to both it and 
retroperitoneal tissue behaves in a manner similar to the 
latter in its reaction to implants. This appears to indicate 
that the transplant resistance encountered in the subcuta-
neous tissue is not due to physical factors, but possibly 
to chemical factors. Williams (40) has stated in his work 
that subcutaneous tumor implants are ultimately rejected. 
However, my studies indicate that tumor implants in sub-
cutaneous tissue are not ultimately rejected, but rather 
that rejection is a function of the concentration of tumor 
material implanted. Tumor mince concentrations below .25~ 
had a high percentage of non-takes in the test groups. This 
may indicate the possible existence of a minimum subcutaneous 
transplant dosage below which, due to a transplant resistance 
factor (TRF) inherent in the subcutaneous tissue, rejection 
takes place. It has also been shown that tumor mince concen-
trations ranging from .25~ to 5% yielded a differential 
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response (mean survival day of the test group - mean survival 
day of the control group) which approached zero as the con-
centration increased. Such results are not consistent with 
transplant resistance imparted by lymphocytes or antigen-
antibody reactions. Therefore, my studies agree with the 
work done by ¢rskov (31), Haxthausen (19), and Rabinovici 
(33). Results of this nature are only capable of explaination 
if one adopts the hypothesis of a constant amount of trans-
plant resistance factor (TRF) in a given volume of sub-
cutaneous tissue, with no buildup or mobilization of the 
factor in response to increased dosages of implant material. 
It has been shown that a saline extract of subcutaneous 
tissue is capable of imparting to other areas a form of 
transplant resistance. This resistance has been found to be 
more evident in the supernatant fluid of a centrifuged 
subcutaneous tissue extract than in the non-centrifuged 
extract containing both cells and fluid of the tissue. 
Evidence of this nature seems to point to the fluid or 
humoral portion of the cell as the major source of subcu-
taneous transplant resistance and/or rejection. The ability 
to impart transplant resistance to other areas is important 
from a number of aspects. If the TRF is in some way respon-
sible for the high degree of non-takes in skin transplantation, 
then blockage of this factor would greatly enhance such 
transplantations. Also, it was observed that the TRF was 
capable of rejecting tumor mince concentrations below .25%, 
25 
while above this concentration it was unable to do so. This, 
it was hypothesized, was due to the TRF being constant in 
a given volume of subcutaneous tissue. If the factor were 
capable of being extracted and concentrated, then it would be 
quite conceivable that large doses of the TRF might be 
capable of handling greater amounts of tumor tissue and 
either inhibiting or destroying the latter. Such a substance 
might, in effect, be a good chemotherapeutic agent in the 
management and treatment of malignant tumors. 
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SUMMARY 
The determination of a differential response to a homograft 
implant by two homologous tissues has been presented. The homologous 
tissues used were those of the retroperitoneal and subcutaneous areas. 
The homograft material was the Walker 256 carcinoma. There is a decrease 
in the ability of the transplant resistance factor as the concentration 
of the implant increases. Transplant resistance is able to be imparted 
to other areas by means of a subcutaneous tissue extract. The major 
source of said resistance appears to be contained within the fluid 
portion of the tissue cells. 
,.,., 
27 
REFERENCES 
1. Bhishagratna, K.K.L.: An English Translation of the Sushruta Samhita, 
Based on Original Sanskrit Text, 3 Vols. Bose, Calcutta, 1907-1916. 
2. Billingham, R.E., Brent, L., and Medawar, P.B.: The Antigenic Stimulus 
in Transplantation Immunity. Nature, 178:514,195,6. 
3. Brent, L, and Gowland, G.: Cellular Dose and Age of Host in the 
Induction of Tolerance. Nature (London), 192:1265, December 1961. 
4. Cannon, P.R., and Sullivan, F.L.: Proc. Soc. Exper. Biol. and Med., 
xxix, 517, 1931-32 •. 
5. Danforth, C.H., and Foster, F.: Skin Transplantation as a Means of 
Studying Genetic And Endocrine Factors in the Fowl. J. Exper. Zool. 
52:443, 1929. 
6. Dare,r, D.A.: Plasma Cells in the Reaction Against Rabbit Tissue 
Homografts. Nature (London), 163:98, 1949. 
7. Davis, J.s.: The Story of Plastic Surgery. Ann. Surg., 113:641, 1941. 
8. Dunham, L.J., and Stewart, H.L.: A Survey of Transplantable'and 
Transmissable Animal Tumors. J. Nat. Cancer Inst., 13:1299, 1950. 
9. Ehrich, W.E., Drabkin, D.L., and Formar, C.: Nucleic Acid and the 
Production of Antibody by Plasma Cells. J.Exper. Med., 90:157, 
1949. 
10. Ehrich, W.E., and Harris, T.N.: The Site of Antibody Formation, 
Science, 101:28, 1945. 
11. Foster, D.G., and Hanrahan, E.M.: Observations on a Skin Homograft, 
After 60 Days of Pyribenzamine Therapy. Bull. Johns Hopkins 
Hosp., 82:501, 1948. 
12. 
13. 
14. 
15. 
16. 
Gaines, M. T.: A Review of Some of the Histogenic Relationships of the 
Skin. South. M.J., 32:202, 1939. 
Gillies, H., and Millard, D.R., Jr.: The Principles and Art of Plastic 
Surgery. Little, Brown, and Company, Boston, 1957. 
Gnudi, M.T. and Webster, J.P.: The Life and Times of Gaspere 
Togliacozzi. Herbert Reichner, New York, 1950. 
Greene, H.S.N.: Heterologous Transplantation of Mammalian Tumors. 
II The Transfer of Human Tumors to Alien Species. J. Exper. Med., 
73:475, 1941. 
Greene, H.S.N.: The Transplantation of Tumors to the Brain of 
Heterologous Species. Cancer Res., 11:64, 1951. 
REFERENCES / 
17. Handler, A.H.: Forum on Terminology. Transpl. Bull., 1:27, 1953~ 
18. Harris, T.N., and Ehrich, W.E.: The Fate of Injected Particulate 
Antigens in Relation to Formation Antibodies. J. Exper. Hed., 
84:157, August 1946. 
28 
19. Haxthausen, H.: Investigations into the Part Played by the Skin as 
an Independent Producer of Antibodies. Acta Dermatovenereologica, 
20:396, 1939. 
20. Kahn, R.L.: Tissue Response in Immunity. Ann. New York Acad. Sc., 
59:281, 1955. 
21. Koelsche, G.A.: The Role of Immune Mechanisms in Tissue Transplantation 
and Resistance to Cancer. Ann. Allergy, 18:1187, November 1960. 
22. Loeb, L.: The Biological Basis of Individuality, Charles C. Thomas, 
Springfield, Ill., 1945. 
23. Longmire, W.P. Jr., and Smith, w.s.: Homologous Transplantation of 
Tissues, Review of the Literature. A.M.A. Arch. Surgl, 62:443, 
March 1951. 
24. Lutz, P.R. et al: The Cheek Pouch of the Hamster as a Site for the 
Transplantation of a Hethylcholanthrene Induced Sarcoma. Cancer 
Res., 11:64, 1951. • 
25. Maximo~ A.A. and Bloom, W.: A Textbook of Histology, ed. 4 W.B. 
Saunders Company, Philadelphia, 1944. 
26. McMaster, P.D.: Sites of Antibody Formation, in the Nature and 
Significance of the Antibody Response, A.M. Pappenheimer, Jr. ed. 
p 13 Columbia Univ. Press, New York, 1953. 
27. Medawar, P.B.: Second Study of Behavious and Fate of Skin Homografts 
in Rabbits. J. Anat., 79:157, 1945. 
28. Medawar, P.B.: Notes on the Problem of Skin Homografts. Bull. War. 
Med., 4:1, 1953. 
29. l'1edawar, P.B~: Nature, 189:1407, 1961. 
30. Oakley, C.L., Batty, I., and Warrack, G.H.: Local Production of 
Antibodies. J. Path. and Bact., 63:33, January 1951. 
31. ¢rokov, J. and Andersen, E.K.: z. Irnmunit~tsforsch, xcii:487, 1938. 
32. Patterson, W.B., Chute, R.N., and Sommers, S.C.: Transplantation of 
Human Tumors into Cortisone Treated Hamsters. Cancer Res. 14: 
656, 1954. 
REFERENCES 29 
33. Rabinovici, N.: The Fate of Skin Homotransplants Performed on 
Previously X-Rayed Rats. Plast. Reconstruct. Surg., 2:413, 1947. 
34. Rostenberg, A. Jr., and Brunner, M.J.: Theories of Antibody Formation. 
Ann. Allergy, 8:108;148, January - February 1950. 
35. Southam, C.M., Moore, A.E., and Rhoads, C.P.: Science, 125:158, 1957. 
36. Teir, H.: Acta Path. et Microbial. Scandinav., 27:645, 1950. 
37. Teir, H.: Acta Path. et Microbial. Scandinav., 30:158, 1952. 
38. Teir, H., and Ravanti, K.: Exper. Cell Res., 5:500, 1953. 
39. Thorbecke, G.J. and Keuning, F.J.: Antibody Formation in Vitro by 
Hemopoietic Organs After Subcutaneous and Intravenous Immunization. 
J. Immunol., 70:129, January 1953. 
40. Williams, R.G.: The Vascularity of Normal and Neoplastic Grafts in 
Vivo. Cancer Res., II:l39, 1951. 
41. Wise, F., and Sulzberger, M.B.: Year Book of Dermatology and 
Syphilology, p 543, Year Book Publishers Inc., Chicago, 1936. 
